{"name":"Zhejiang Medicine Co., Ltd.","slug":"zhejiang-medicine-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOMXF0TEJWYTFRd3pZeFJ6djVfVTlKMF9kbG5ENzhIN1VpTmlua3V2a2V3MmZyU2g5dm80Y1NwRVVab2VoRVRNLXJOeGU2UTFuS1dsb0xfdTJab2tmUkl0eklEOEJ1dkI4bWgzSGZvWUhCT2JNSldnb29xTi1RODVSNjl5ZHlZLWJmTkk5SWxVU0tZZnZsVEl5cktaWGxKRGtQZ3IyT01NN0psdHVVZGxraFpyS3lRb2Z2b1JadWo2ZDNQVHVV?oc=5","date":"2026-03-18","type":"pipeline","source":"Markets Mojo","summary":"Zhejiang Medicine Stock Hits Day Low of CNY 15.91 Amid Price Pressure - Markets Mojo","headline":"Zhejiang Medicine Stock Hits Day Low of CNY 15.91 Amid Price Pressure","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQamFBbXgzQ1N5NkVmcGRGYUM5LUdXU1c5aGwzdTY0VFJBd0owdWN5M2lkc1lzTlR2ZXdPNEgtVG1pUHcxa21vOHJvUDVyOVlBQk1PQ0ZFT0liQVpsUHE2blpxTmVZYk5Ma0RNMjVmS1VnV2sxNENvRk5KcVZ3cmtOLWRSVVVsSzBYNE9vcTZKNjZGbFRzWjVyWmw2NDlvU0hhX2ZlZFNMRXFFa1RhSkZrMTEwcEs0bFZ1VXJyZndKLXM?oc=5","date":"2026-03-12","type":"pipeline","source":"Markets Mojo","summary":"Zhejiang Medicine Co. Hits Day Low of CNY 17.50 Amid Price Pressure - Markets Mojo","headline":"Zhejiang Medicine Co. Hits Day Low of CNY 17.50 Amid Price Pressure","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOYXBqbVZGVk04Z1NaSmswYnM1Y1RmYlByVWJHTWJMMWtVTG4ycVl5WE5jYmkzcy11RVRTSFAteHQ2b0lEN1pwajhIeGc4cW5FMGF5MXBESEtsVHFPdjRmTnB1eHFtSkNYM1k3UmhQNVN1WmI3LTlDaFA0T0tqZFdrR0NneGx3WTB4RHBRQWEzTlVfT3hyd1hTSk9Lem14QzVpQVZrdmY1MFc2Smg5QTZuemgyVU1jYTRZTnJuMQ?oc=5","date":"2026-03-12","type":"pipeline","source":"Markets Mojo","summary":"Zhejiang Medicine Hits Day High with Strong 5.61% Intraday Surge - Markets Mojo","headline":"Zhejiang Medicine Hits Day High with Strong 5.61% Intraday Surge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPTGhPNGhJY0QxeW5vZm5lVDF2OUFTWFZqUllHTmNjYnZ5S0ZBcU1GeFRWc1oxLXJJR2ZRcTdwa3Rkd0lsSjhycW45SmQwZXhKUk5ick9SMUR4X2szOTdoMmMxZ3ZhOGNfZEIycm1oZi1mWEloTkRoa1N5ZHVqcmRCYzRNOEp0dFVMVXQwQkpzcW0?oc=5","date":"2026-02-18","type":"earnings","source":"Insightace Analytic","summary":"Pharma Blister Packaging Machines Market Profit to Sources Report 2026 to 2035 - Insightace Analytic","headline":"Pharma Blister Packaging Machines Market Profit to Sources Report 2026 to 2035","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE1aLVFzYkI0SXhfT244cUdKNV91Wjg2bmR6STd3TkZIX2RQUnI3aS0xXzIzcHZ2SXAySTljb1NOSUpTelR6Y0VNazQxLVdVTGVNd2pBQjF4aFNEUXhjQ2c?oc=5","date":"2025-10-14","type":"pipeline","source":"Market.us","summary":"Vitamin D Market Size, Share | CAGR of 6.2% - Market.us","headline":"Vitamin D Market Size, Share | CAGR of 6.2%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNM2V0VElQcHUtUGpnSl9rcF9NSXRTNURjclVVa2VSZ0dnM2ZJNzU5WFViSHpmaTU1SjViakQteFR2Q1ZjSFNMY2JKWENkcDY3UmtnMWFUR2VEenNzaFltUEctaFdHOXJpQl92VHc4WG0xS1oya2JVTm9PN0twUE9Nd25CLVpXeS1WZVhkV0tYS1gtUFNPS1NGODI5OEROS25xcnJZV3B3?oc=5","date":"2025-08-12","type":"trial","source":"BioWorld News","summary":"Fosun out-licenses phase II DPP-1 to newco Expedition for $645M - BioWorld News","headline":"Fosun out-licenses phase II DPP-1 to newco Expedition for $645M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNcHFmS3VieGZmcFcyc002QzdmazFyQ25XSHp3NWJPRDZyNTdJQ0VyYnF5QUhkWHNLaVcydldjZXFjbGRfNmF4VE9maEJXZWZyeW5BSlhNY1o3d1VId1M5cDZGUmZBUzl3U2dobVdPN0ZaaHZUZXFxaFRfZVRnSUpxT2NkVXZGVE4tRUt0am0tUGlhY0E0eWNDcWpFMGJVX3lIcUZTY2V4cE1ybEFVSlEzN0ExWm85cFRSWC1tWg?oc=5","date":"2024-10-02","type":"trial","source":"Bloomberg.com","summary":"Chinese Drugmaker on Trial for Contamination Still Sells in US - Bloomberg.com","headline":"Chinese Drugmaker on Trial for Contamination Still Sells in US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxPVm9YU1JzN3JQRjdfckppSzREZDhWWEk3RUxjd0dzZGMteVBfOW96a1N6ZHJJejZSUEJpcnlpYnc5TnozZ0hBdVdzZzlfUXA2bzFId2VVdEZaVzNjX1lIUzdhWmVLOXdjcklsS0o2bldQRXV3N3dOVlJVOEFxcjdmck1GOE1pRVAwSnRWT0hydWVLR3laU2JMbGY2dmR2RXkzaUdIXzlnVFZvbmZGU3N2WV9UU05qSzhIdTJORm9LbjR2cWFoYWJKbjlSMXp6a1NQVGx1Z1lETFo2UHAxTWhHWTVxQnkyVmFUdmZkTUIzN2trZlZ0SHY4SzRpZVB1M0RESC11U0NhRXA4OUxfbmwzSTVJcldxUQ?oc=5","date":"2020-03-19","type":"pipeline","source":"PR Newswire","summary":"Zhejiang Hisun Pharmaceutical Co. Ltd.: Favipiravir Works - Preliminary Clinical Studies Suggest Positive Effects on COVID-19 Patients - PR Newswire","headline":"Zhejiang Hisun Pharmaceutical Co. Ltd.: Favipiravir Works - Preliminary Clinical Studies Suggest Positive Effects on COV","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOdExYanZlX1FWb2pHeTNRdWhPZllTM05VckJXMWJnamhzMVdfNURreTJZcmU3b19WM0lFRGRwbnNBblNhTHBnWXJzTnljaGpXMjNMdDJyTVRYbm56ZjhPbVJtZUtjUTNLTFU5YUJKSm1xVlhfeUhfeW0zQXFfblNWUFAtV2thaDdVSzhfUjM5MjBXWFZVZ3ZNQQ?oc=5","date":"2019-04-23","type":"trial","source":"BioProcess International","summary":"A Harmonized Approach to Data Integrity - BioProcess International","headline":"A Harmonized Approach to Data Integrity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQdTd1SnpKNk1mMTBsOW1qV2ZJM29OaHhWcVBmNVFCMFlKVnBWaURwMzJFM2hUMEZ4WUd2S0c1OE1LYVBWV2lzWC1ZYU1WWUh6YVZrQm1iTUhMZVEzQ2JnT1pQYi1aTmtYRy13ZGtQaEFfNTVnTExUUVVrYU9FTTk4OU02eFZSeUxMTnVaUkJRcmx1dmdk?oc=5","date":"2018-12-11","type":"regulatory","source":"Pharmacy Times","summary":"Valsartan Recall: FDA Issues Warning to API Manufacturer - Pharmacy Times","headline":"Valsartan Recall: FDA Issues Warning to API Manufacturer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNQUFiTTd5d0ZydDhMR0U4bzhEVE9NeUFYaGhhMjF0M3JYc3hYZkZxbXRpMFZzVmlqb3Vla1l3TnV1THJnTWdjRGF1UXVhRDZIR29JekM1ZjU2Q3k0d01FalBEMEt4b2RsZVlrLS1UekVNam5NbzlVdzNFNUV3SEhNTGZuQXR6Zw?oc=5","date":"2018-09-20","type":"pipeline","source":"Pharmaceutical Technology","summary":"A summer of manufacturing disasters for Chinese pharma - Pharmaceutical Technology","headline":"A summer of manufacturing disasters for Chinese pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOdmZlN2FoYjk2UlBZNG9JdW9uZENla095VUdGamZtQ0lNelVEOG55UnAtMERuME1GYjVRcFhkQ21Pc0ZobHczUXNVR0p3MldyZjhjSHB4ekJWUEpDX01keUh3N3dKUW9ILWhGTDN0OWhhNGhQZ0xyaHlSc05hbVBndWxFZDhMSktkR1Zla0kzZ3YzRnFtcHpYNXFUX1RoSDdSSmdmX2hJQmR1ckdnb3c?oc=5","date":"2016-02-10","type":"regulatory","source":"RAPS.org","summary":"US FDA Inspections in China: An Analysis of Form 483s from 2015 - RAPS.org","headline":"US FDA Inspections in China: An Analysis of Form 483s from 2015","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}